FDA Approves Xacduro for Difficult-to-Treat Bacterial Pneumonia

TUESDAY, May 30, 2023 -- The U.S. Food and Drug Administration has approved Xacduro (sulbactam for injection; durlobactam for injection) as a new treatment for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia...

https://www.drugs.com/news/fda-approves-xacduro-difficult-bacterial-pneumonia-11...

Source: Drugs.com - Daily MedNews - May 30, 2023 Category: General Medicine Source Type: news

More News: Bacterial Pneumonia | Food and Drug Administration (FDA) | General Medicine | Hospitals | Pneumonia